About LifeMap Sciences
LifeMap Sciences (“LifeMap”) is a life sciences technology company dedicated to providing the leading edge Integrated Biomedical Knowledgebase. Operations worldwide are carried out from its offices in California, Massachusetts, New Jersey, Tel Aviv and Hong Kong. LifeMap is a subsidiary of BioTime, Inc.
LifeMap’s Integrated Biomedical Knowledgebase and discovery platform for biomedical research currently includes GeneCards®: the leading human gene database; LifeMap Discovery®™, the database of embryonic development, stem cell research and regenerative medicine; MalaCards, the human disease database; and GeneAnalytics™, a novel gene set analysis tool which leverages our Integrated Biomedical Knowledgebase. LifeMap’s products are used in more than 3,000 institutions including academia, research hospitals, patent offices, and leading biotechnology and pharmaceutical companies.
LifeMap Sciences intends to continually improve the quality of its products, and is pursuing several new Internet and informatics products with substantial, rapid-revenue growth potential, leveraging its existing products and their large user base of life scientists. LifeMap also intends to extend its offerings to the field of mobile health via its subsidiary LifeMap Solutions, Inc.
Jul 10, 2014
LifeMap Sciences, a Subsidiary of BioTime, Announces Release of GeneCards® Version 3.12 and the Introduction of GeneCards Plus™.
LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., announced today the release of GeneCards® Version 3.12. The new release is available at www.genecards.org. GeneCards® is an online database that provides comprehensive information on all known human genes. The new release features the launch of LifeMap Science’s Premium Services platform, which offers our strong user base access to GeneCards Plus’ powerful tools and advanced functionality integrated with the LifeMap Integrated Knowledgebase, which includes GeneCards®, MalaCards and LifeMap Discovery®